Live Quote · NASDAQNCELHealthcare· Biotechnology

NewcelX Ltd.

$3.85 0.00%(+$0.00)
TickerSpark Score
64/100
Mixed
87
Valuation
60
Profitability
60
Growth
64
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NCEL research report →

52-Week Range8% of range
Low
$1.83
Current
$3.85
High
$28.03
Company Overviewwww.newcelx.com

About the company

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.

CEO
Ronen Twito
IPO
2025
Employees
11
HQ
Zurich, CH

Price Chart

-85.02% · this period
$27.90$14.89$1.88Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.73M
P/E
-0.42
P/S
0.00
P/B
1.79
EV/EBITDA
0.04
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
41.94%
ROIC
-75.27%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-8,300,000 · -319.02%
EPS
$-2.16 · 91.79%
Op Income
$-2,474,000
FCF YoY
35.06%
Performance & Tape
52W High
$28.03
52W Low
$1.83
50D MA
$3.47
200D MA
$5.49
Beta
0.92
Avg Volume
54.81K

Get TickerSpark's AI analysis on NCEL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 27, 26Samuel Olivierbuy114,545
Apr 27, 26Samuel Olivierbuy81,818
Apr 27, 26Revel Michelbuy54,545
Apr 27, 26Revel Michelbuy76,363
Mar 18, 26Galili Tamarother9,117
Mar 18, 26Twito Ronenother0
Mar 18, 26Revel Michelother0
Mar 18, 26Revel Michelother9,117
Mar 18, 26Hagai Omriother11,396
Mar 18, 26Samuel Olivierother13,676
Coverage · NCEL

Our NCEL coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NCEL yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NCEL report →
Internal Compare

Similar companies

Peers in the same neighborhood.